Literature DB >> 29140890

Selecting an HIV Test: A Narrative Review for Clinicians and Researchers.

Christopher B Hurt1, Julie A E Nelson, Lisa B Hightow-Weidman, William C Miller.   

Abstract

Given the many options available, selecting an HIV test for a particular clinical or research setting can be daunting. Making an informed decision requires an assessment of the likelihood of acute infection in the test population and an understanding of key aspects of the tests themselves. The ability of individual tests to reliably detect HIV infection depends on the target(s) being detected, when they can be expected to be present after infection, and the concentration of stable target in test specimens, all of which are explained by the virologic and serologic events after infection. The purpose of this article is to review the timeline of HIV infection, nomenclature, and characteristics of different tests; compare point-of-care and laboratory-based tests; discuss the impact of different specimens on test performance; and provide practical advice to help clinicians and researchers new to the field select a test that best suits their needs.

Entities:  

Mesh:

Year:  2017        PMID: 29140890      PMCID: PMC5718364          DOI: 10.1097/OLQ.0000000000000719

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  25 in total

1.  Rapid testing strategies for HIV-1 serodiagnosis in high-prevalence African settings.

Authors:  Richard J Wright; Jeffrey S A Stringer
Journal:  Am J Prev Med       Date:  2004-07       Impact factor: 5.043

2.  Repeatedly false-negative rapid HIV test results in a patient with undiagnosed advanced AIDS.

Authors:  Patricia Brown; Joseph R Merline; Diane Levine; Lucio Román Minces
Journal:  Ann Intern Med       Date:  2008-07-01       Impact factor: 25.391

3.  Time Until Emergence of HIV Test Reactivity Following Infection With HIV-1: Implications for Interpreting Test Results and Retesting After Exposure.

Authors:  Kevin P Delaney; Debra L Hanson; Silvina Masciotra; Steven F Ethridge; Laura Wesolowski; Sherry Michele Owen
Journal:  Clin Infect Dis       Date:  2016-10-12       Impact factor: 9.079

4.  Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group.

Authors:  L R Petersen; G A Satten; R Dodd; M Busch; S Kleinman; A Grindon; B Lenes
Journal:  Transfusion       Date:  1994-04       Impact factor: 3.157

Review 5.  Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure.

Authors:  M P Busch; G A Satten
Journal:  Am J Med       Date:  1997-05-19       Impact factor: 4.965

6.  Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.

Authors:  David T Kuhar; David K Henderson; Kimberly A Struble; Walid Heneine; Vasavi Thomas; Laura W Cheever; Ahmed Gomaa; Adelisa L Panlilio
Journal:  Infect Control Hosp Epidemiol       Date:  2013-09       Impact factor: 3.254

7.  Announcement: Updated Guidelines for Antiretroviral Postexposure Prophylaxis after Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV - United States, 2016.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-05-06       Impact factor: 17.586

8.  Multi-centre evaluation of the Determine HIV Combo assay when used for point of care testing in a high risk clinic-based population.

Authors:  Damian P Conway; Martin Holt; Anna McNulty; Deborah L Couldwell; Don E Smith; Stephen C Davies; Philip Cunningham; Phillip Keen; Rebecca Guy
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

9.  HIV Trends in the United States: Diagnoses and Estimated Incidence.

Authors:  H Irene Hall; Ruiguang Song; Tian Tang; Qian An; Joseph Prejean; Patricia Dietz; Angela L Hernandez; Timothy Green; Norma Harris; Eugene McCray; Jonathan Mermin
Journal:  JMIR Public Health Surveill       Date:  2017-02-03

10.  Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San Francisco.

Authors:  Christopher D Pilcher; Brian Louie; Shelley Facente; Sheila Keating; John Hackett; Ana Vallari; Chris Hall; Teri Dowling; Michael P Busch; Jeffrey D Klausner; Frederick M Hecht; Sally Liska; Mark W Pandori
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

View more
  12 in total

Review 1.  Bringing HIV Self-Testing to Scale in the United States: a Review of Challenges, Potential Solutions, and Future Opportunities.

Authors:  Kevin Steehler; Aaron J Siegler
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

2.  Acceptance of Routine HIV Testing by Hospitalized Adolescents and Young Adults.

Authors:  Avni M Bhalakia; Hina J Talib; Jaeun Choi; Dana Watnick; Risa Bochner; Donna Futterman; Elissa Gross
Journal:  Hosp Pediatr       Date:  2018-04

3.  Filtration-assisted magnetofluidic cartridge platform for HIV RNA detection from blood.

Authors:  Alexander Y Trick; Hoan Thanh Ngo; Anju H Nambiar; Marisa M Morakis; Fan-En Chen; Liben Chen; Kuangwen Hsieh; Tza-Huei Wang
Journal:  Lab Chip       Date:  2022-03-01       Impact factor: 7.517

4.  Ending the HIV Epidemic in the United States Must Start with the South.

Authors:  Kirk D Henny; William L Jeffries
Journal:  AIDS Behav       Date:  2019-10

5.  Performance evaluation of the Aptima HIV-1 RNA Quant assay on the Panther system using the standard and dilution protocols.

Authors:  Rebecca Rossetti; Tara Smith; Wei Luo; Jennifer Taussig; Mariah Valentine-Graves; Patrick Sullivan; Jessica M Ingersoll; Colleen S Kraft; Steve Ethridge; Laura Wesolowski; Kevin P Delaney; S Michele Owen; Jeffrey A Johnson; Silvina Masciotra
Journal:  J Clin Virol       Date:  2020-06-01       Impact factor: 3.168

6.  Neurologic Complications of Acute HIV Infection.

Authors:  Kathryn B Holroyd; Anastasia Vishnevetsky; Maahika Srinivasan; Deanna Saylor
Journal:  Curr Treat Options Infect Dis       Date:  2020-06-08

7.  Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP Care.

Authors:  Kevin F Kamis; Grace E Marx; Kenneth A Scott; Edward M Gardner; Karen A Wendel; Mia L Scott; Angela E Montgomery; Sarah E Rowan
Journal:  Open Forum Infect Dis       Date:  2019-06-27       Impact factor: 3.835

8.  'Informed and empowered': a mixed-methods study of crowdsourcing contests to promote uptake of HIV self-testing kits among African Americans.

Authors:  Allison Mathews; Donaldson Conserve; Hailey Mason; Le'Marus Alston; Stuart Rennie; Joseph Tucker
Journal:  J Virus Erad       Date:  2020-04-30

Review 9.  Emerging Designs of Electronic Devices in Biomedicine.

Authors:  Maria Laura Coluccio; Salvatore A Pullano; Marco Flavio Michele Vismara; Nicola Coppedè; Gerardo Perozziello; Patrizio Candeloro; Francesco Gentile; Natalia Malara
Journal:  Micromachines (Basel)       Date:  2020-01-22       Impact factor: 2.891

Review 10.  Advances in Continuous Microfluidics-Based Technologies for the Study of HIV Infection.

Authors:  Joëlle Eid; Marylène Mougel; Marius Socol
Journal:  Viruses       Date:  2020-09-04       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.